SCHEMBL6898006

SCHEMBL6898006

CC(C)(C)[Si](C)(C)Oc1cc(OCc2ccccc2)c(OCc2ccccc2)c(Cl)c1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.40
THRB P10828 1/20 0.40
MAPK14 Q16539 3/20 0.38
SMN1; SMN2 Q16637 5/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4E B2RXH2 1/20 0.37
CCR5 P51681 2/20 0.37
ELANE P08246 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 1/20 0.36
STAT3 P40763 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6449283 0.76 CCR5 (0.51) SMN1; SMN2CCR5LMNAHTTRAB9A
SCHEMBL14511752 0.76 SLC6A4 (0.52) SMN1; SMN2CCR5LMNAHTTRAB9A
SCHEMBL6784368 0.75
SCHEMBL7073094 0.75 MEN1 (0.45) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL4875917 0.74 GLRA1 (0.50) THRATHRBSMN1; SMN2KDM4EELANE
SCHEMBL4874863 0.73 MEN1 (0.48) SMN1; SMN2MEN1KMT2AELANE
SCHEMBL14511787 0.73 PTGER1 (0.45) SMN1; SMN2KDM4ECCR5MAPTMAPK1
SCHEMBL1107091 0.73 PTGER1 (0.45) SMN1; SMN2CCR5MAPTMAPK1TDP1
SCHEMBL2901054 0.72 MAOB (0.47) SMN1; SMN2LMNARAB9ANPC1
SCHEMBL30008548 0.72 MEN1 (0.44) MEN1KMT2AKDM4EMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8980951-B2 Sesquiterpenes for antifungal applications KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2015-03-17 US disclosed
US-20140135404-A1 SESQUITERPENES FOR ANTIFUNGAL APPLICATIONS KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2014-05-15 US disclosed
US-6727277-B1 BENZO(A)XANTHENE DERIVATIVES; LYMPHATIC ABSORPTION INTENSIFIERS 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE INHIBITORS KANSAS STATE UNIVERSITY RESEARCH FOUNDATION 2004-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140135404-A1 SESQUITERPENES FOR ANTIFUNGAL APPLICATIONS DPM1, ERG28, MDN1 THRA 3948/4885THRB 4014/4885MAPK14 2655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.